Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Nov 4, 2024
Open Peer Review Period: Nov 4, 2024 - Dec 30, 2024
Date Accepted: May 6, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Sodium Oxybate as a Potential New Treatment for Catatonia in Patients With Depression, Bipolar Disorder, or a Psychotic Disorder: Protocol for a Randomized Controlled Trial

Bot L, van Mill JG, Smarius LJCA, Hoogendoorn AW, Storosum BWC, Vinkers CH, Jacobs GE, Lammers GJ, Heller HM, Colen-de Koning JCA, van der Vlugt JJB, Oudijn MS, van Noorden MS, Bet PM, Fronczek R, van der Heijden HS, Lange SMM, van der Werf YD, van Exel ER

Sodium Oxybate as a Potential New Treatment for Catatonia in Patients With Depression, Bipolar Disorder, or a Psychotic Disorder: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2025;14:e68356

DOI: 10.2196/68356

PMID: 40705436

PMCID: 12332447

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Per the author's request this version is not available.